Scope of the
Report
The report entitled “US Tardive Dyskinesia Market: Size, Trends & Forecasts (2016-2025)”, provides analysis of the US tardive dyskinesia market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the major drugs (both existing and in pipeline) analysis, by penetrations, by revenue, etc.
The report entitled “US Tardive Dyskinesia Market: Size, Trends & Forecasts (2016-2025)”, provides analysis of the US tardive dyskinesia market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the major drugs (both existing and in pipeline) analysis, by penetrations, by revenue, etc.
Request a sample
of this report @ http://www.orbisresearch.com/contacts/request-sample/185438 .
Furthermore, the report also assesses the key opportunities in the market
and outlines the factors that are and will be driving the growth of the
industry. Growth of the overall US tardive dyskinesia market has been
forecasted for the years 2016-2025, taking into consideration the previous
growth pattern, the growth drivers and the current and future trends.
Valeant Pharmaceuticals, Neurocrine Biosciences and Teva Pharmaceutical
Industries are some of the key companies in the US tardive dyskinesia market.
The company profiling of these companies has been done in the report, which
includes business overview, financial overview and respective business
strategies of the companies.
Company Coverage
Valeant Pharmaceuticals (Tertrabenazine)
Neurocrine Biosciences (Valbenazine)
Teva Pharmaceutical Industries (SD-809)
Valeant Pharmaceuticals (Tertrabenazine)
Neurocrine Biosciences (Valbenazine)
Teva Pharmaceutical Industries (SD-809)
Executive Summary
Psychosis is a condition described as loss of contact with reality. And the people suffering from this condition are called psychotics. Some of the signs and symptom of psychosis are: difficulty in concentrating, depressed mood, sleeping too much or not enough, anxiety, etc. The two main types of psychiatric disorder related to tardive dyskinesia are Schizophrenia and Bipolar Disorder.
Psychosis is a condition described as loss of contact with reality. And the people suffering from this condition are called psychotics. Some of the signs and symptom of psychosis are: difficulty in concentrating, depressed mood, sleeping too much or not enough, anxiety, etc. The two main types of psychiatric disorder related to tardive dyskinesia are Schizophrenia and Bipolar Disorder.
Involuntary movements of face, lips, tongue, extremities and trunk, is
called tardive dyskinesia. This disease is caused by regular and long term
intake of dopaminergic antagonist medications/ antipsychotics as a prescription
for schizophrenia and bipolar disorder. Some of the signs and symptoms of
tardive dyskinesia are grimacing, tongue movements, lip smacking, lip
puckering, pursing of the lips, excessive eye blinking, etc.
Purchase a copy of
US Tardive Dyskinesia Market
visit @ http://www.orbisresearch.com/contact/purchase/185438 For
more information contact sales@orbisresearch.com .
Tardive dyskinesia has many different treatments, including vitamin E,
benzodiazepines, levodopa, reserpine, botullinum toxin, tetrabenazine,
dopamine-depleting agents, and calcium channel blockers. Along with these, two
new treatments are in the pipeline: Valbenazine and SD-809.
The US tardive dyskinesia market is expected to increase at a significant
growth rate during the forecasted period (2016-2025). The US tardive dyskinesia
market is supported by various growth drivers, such as increase in number of
schizophrenia patients, rising bipolar disorder patients, etc. Yet, the market
faces certain challenges, such as, increased use of atypical antipsychotics,
under-diagnosed market, side effects of drugs, etc.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/us-tardive-dyskinesia-market-size-trends-and-forecasts-2016-2025 .
Some points from TOC:
1. Executive Summary
2. Introduction
2.1 Psychosis: An Overview
2.1.1 Psychosis
2.1.2 Psychotic Disorder
2.1.3 Schizophrenia
2.1.4 Bipolar Disorder
2.2 Antipsychotics: An Overview
2.3 Tardive Dyskinesia: An Overview
2.3.1 Signs and Symptoms
2.3.2 Causes
2.3.3 Treatment
2.3.4 Existing and Pipeline Drugs
2.1 Psychosis: An Overview
2.1.1 Psychosis
2.1.2 Psychotic Disorder
2.1.3 Schizophrenia
2.1.4 Bipolar Disorder
2.2 Antipsychotics: An Overview
2.3 Tardive Dyskinesia: An Overview
2.3.1 Signs and Symptoms
2.3.2 Causes
2.3.3 Treatment
2.3.4 Existing and Pipeline Drugs
3. US Market Analysis
3.1 US Tardive Dyskinesia Market: An Analysis
3.1.1 US Tardive Dyskinesia Market by Number of Patients
3.1.2 US Tardive Dyskinesia Market Number of Patients by Segments
3.1.3 US Tardive Dyskinesia Market Number of Patients by Severity
3.2 US Tardive Dyskinesia Drugs Market; An Analysis
3.2.1 US Valbenazine Market by Penetration
3.2.2 US Valbenazine Market by Number of Patients
3.2.3 US Valbenazine Market by Price and Revenue
3.2.4 US SD-809 Market by Penetration
3.2.5 US Tetrabenazine Market (For TD) by Penetration
3.1 US Tardive Dyskinesia Market: An Analysis
3.1.1 US Tardive Dyskinesia Market by Number of Patients
3.1.2 US Tardive Dyskinesia Market Number of Patients by Segments
3.1.3 US Tardive Dyskinesia Market Number of Patients by Severity
3.2 US Tardive Dyskinesia Drugs Market; An Analysis
3.2.1 US Valbenazine Market by Penetration
3.2.2 US Valbenazine Market by Number of Patients
3.2.3 US Valbenazine Market by Price and Revenue
3.2.4 US SD-809 Market by Penetration
3.2.5 US Tetrabenazine Market (For TD) by Penetration
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1
(214) 884-6817; +9164101019
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment